{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-124107","form_type":"8-K","ticker":"EQ","cik":"0001746466","company_name":"Equillium, Inc.","filed_at":"2026-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.061807+00:00","generated_at":"2026-05-15T09:02:29.337228+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Equillium Q4 2025 revenue $0, net loss $3.8M; cash runway into 2029 after $35M financing","bullets":["Q4 2025 revenue $0 (vs $4.4M Q4 2024); FY2025 revenue $0 (vs $41.1M FY2024 from Ono deal).","Net loss Q4 2025 $3.8M ($0.04/share); full year 2025 loss $22.4M ($0.39/share), up from $8.1M loss in 2024.","Cash & equivalents $30.3M at Dec 31, 2025; plus $35M private placement from RA Capital in March 2026.","EQ504 Phase 1 proof-of-mechanism study expected to start mid-2026 with data ~6 months later.","Company believes cash runway funds planned operations into 2029."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-124107","json":"https://secwatch.observer/filing/0001193125-26-124107.json","markdown":"https://secwatch.observer/filing/0001193125-26-124107.md","text":"https://secwatch.observer/filing/0001193125-26-124107.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1746466/000119312526124107/0001193125-26-124107-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1746466/000119312526124107/eq-20260325.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:02:29.337228+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}